Production of ( R )‐1,3‐butanediol via an Isozyme co‐expression Strategy in Escherichia coli
Biotechnology Journal · 2026
DOI: 10.1002/biot.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Huifang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China. Hauptthemen laut MEDLINE: Escherichia coli, Butylene Glycols. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Basic Research Center for Synthetic Biology.
Abstract (Originalsprache)
Microbial cell factories for the production of valuable chemicals often require multi‐step biosynthetic pathways, whose efficiency is frequently limited by the performance and compatibility of pathway enzymes. Here, an isozyme co‐expression strategy was proposed and evaluated in the ( R )‐1,3‐BDO biosynthetic pathway of Escherichia coli . First, nine strains harboring different combinations of three candidate thiolases (AtoB, PhaA, Thl) and three candidate aldehyde dehydrogenases (Bld, Ald, AdhE2) were constructed and evaluated. Among them, the Thl‐PhaB‐Bld strain (B3‐7) exhibited the highest ( R )‐1,3‐BDO production (1.4 g/L). The remaining isozymes (AtoB, PhaA, Ald, and AdhE2) were then overexpressed individually in strain B3‐7, with PhaA and AdhE2 showing the most significant improvement in ( R )‐1,3‐BDO production. Co‐expression of PhaA and AdhE2 further increased the ( R )‐1,3‐BDO titer to 4.2 g/L, representing a 200% increase relative to strain B3‐7. In addition, several metabolic effector molecules were screened as medium supplements, among which citric acid was identified as the most effective for improving ( R )‐1,3‐BDO production. Finally, in glucose‐feeding shake‐flask fermentation, the isozyme co‐expression strain produced 16.2 g/L ( R )‐1,3‐BDO. Collectively, the isozyme co‐expression strategy effectively enhanced ( R )‐1,3‐BDO production and represents a promising approach for optimizing multi‐step biosynthetic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
ORCID-Profile: Yong Chen, Chenjie Zhu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Jiangsu Basic Research Center for Synthetic Biology
Zitieren
APA
Zhang, H., Peng, D., Chen, P., Peng, X., Li, M., Liu, Q., Chen, Y., Zhu, C., Wang, Z., Liu, D., & Ying, H. (2026). Production of ( R )‐1,3‐butanediol via an Isozyme co‐expression Strategy in Escherichia coli. Biotechnology Journal. https://doi.org/10.1002/biot.70224
Vancouver
Zhang H, Peng D, Chen P, Peng X, Li M, Liu Q, et al. Production of ( R )‐1,3‐butanediol via an Isozyme co‐expression Strategy in Escherichia coli. Biotechnology Journal. 2026. doi:10.1002/biot.70224
BibTeX
@article{Zhang2026,
author = {Zhang, Huifang and Peng, Dong and Chen, Pinzhou and Peng, Xiwei and Li, Mengting and Liu, Qingguo and Chen, Yong and Zhu, Chenjie and Wang, Zhenyu and Liu, Dong and Ying, Hanjie},
title = {Production of ( R )‐1,3‐butanediol via an Isozyme co‐expression Strategy in Escherichia coli},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70224}
}
EUVIMED